QuidelOrtho Reports First Quarter 2023 Financial Results
Highlights First quarter revenue of $846.1 million decreased by 16% as reported with non-respiratory revenue up 5% on a supplemental combined basis and respiratory revenue down 72% on a... | May 3, 2023
United States Douglas Bryant Company Or Quidelortho Quidelortho Corporation Nasdaq Quidel Corporation Commission On
Source: marketscreener.com